A pharmaceutical composition comprising an active principle and sulphobetaine

Details for Australian Patent Application No. 2004305421 (hide)

Owner Lek Pharmaceuticals d.d.

Inventors Podobnik, Barbara; Menart, Viktor; Gaberc Porekar, Vladka

Agent Griffith Hack

Pub. Number AU-B-2004305421

PCT Pub. Number WO2005/060989

Priority P-200300318 23.12.03 SI

Filing date 22 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 8 July 2010

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/060989 Priority application(s): WO2005/060989

8 July 2010 Application Accepted

  Published as AU-B-2004305421

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305422-Controlled-release pharmaceutical formulation

2004305419-Catheter assembly with osmolality-increasing fluid